Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Carroll Insider Profile
4 Followers
Michael Carroll, Director at Sonnet BioTherapeutics Holdings, holds 16.50K shares in Sonnet BioTherapeutics Holdings (Ticker: SONN). Most recently, Michael Carroll Bought $4,000 shares of Sonnet BioTherapeutics Holdings on Sep 23, 2016 for an estimated value of 2.52K.
Michael Carroll has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Carroll's holdings
Insider Roles
Director
Roles that Michael Carroll holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 23, 2016 - Sep 23, 2017
Return:-67.40%
The most profitable trade made by Michael Carroll
Michael Carroll's Trading History
List of latest transactions for each holding click on a transaction to see Michael Carroll's performance on stock
You May Also Like
Michael Carroll insider profile FAQ
What is the percentage of profitable transactions made by Michael Carroll?
The percentage of profitable transactions made by Michael Carroll is ―.
What is the average return per transaction made by Michael Carroll?
The average return per transaction made by Michael Carroll is ―.
What stocks does Michael Carroll hold?
Michael Carroll holds: SONN stocks.
What was Michael Carroll’s latest transaction?
Michael Carroll latest transaction was an Informative Buy of $2.52K.
What was Michael Carroll's most profitable transaction?
Michael Carroll’s most profitable transaction was an Informative Buy of SONN stock on September 23, 2016. The return on the trade was -67.40%.
What is Michael Carroll's role in Sonnet BioTherapeutics Holdings?
Michael Carroll's role in Sonnet BioTherapeutics Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.